Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.
Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S. Hofbauer LC, et al. Among authors: dunstan cr. Endocrinology. 1999 Oct;140(10):4382-9. doi: 10.1210/endo.140.10.7034. Endocrinology. 1999. PMID: 10499489
RANK ligand.
Blair JM, Zheng Y, Dunstan CR. Blair JM, et al. Among authors: dunstan cr. Int J Biochem Cell Biol. 2007;39(6):1077-81. doi: 10.1016/j.biocel.2006.11.008. Epub 2006 Nov 23. Int J Biochem Cell Biol. 2007. PMID: 17174136 Review.
Biphasic glucocorticoid-dependent regulation of Wnt expression and its inhibitors in mature osteoblastic cells.
Mak W, Shao X, Dunstan CR, Seibel MJ, Zhou H. Mak W, et al. Among authors: dunstan cr. Calcif Tissue Int. 2009 Dec;85(6):538-45. doi: 10.1007/s00223-009-9303-1. Epub 2009 Oct 30. Calcif Tissue Int. 2009. PMID: 19876584
Fibroblast growth factor 23: a phosphatonin regulating phosphate homeostasis?
Dunstan CR, Zhou H, Seibel MJ. Dunstan CR, et al. Endocrinology. 2004 Jul;145(7):3084-6. doi: 10.1210/en.2004-0354. Endocrinology. 2004. PMID: 15198971 Review. No abstract available.
Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK.
Theoleyre S, Wittrant Y, Couillaud S, Vusio P, Berreur M, Dunstan C, Blanchard F, Rédini F, Heymann D. Theoleyre S, et al. Among authors: dunstan c. Biochim Biophys Acta. 2004 Feb 2;1644(1):1-7. doi: 10.1016/j.bbamcr.2003.10.005. Biochim Biophys Acta. 2004. PMID: 14741739
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Wittrant Y, Theoleyre S, Couillaud S, Dunstan C, Heymann D, Rédini F. Wittrant Y, et al. Among authors: dunstan c. Exp Cell Res. 2004 Feb 15;293(2):292-301. doi: 10.1016/j.yexcr.2003.10.016. Exp Cell Res. 2004. PMID: 14729467
Osteoprotegerin differentially regulates protease expression in osteoclast cultures.
Wittrant Y, Couillaud S, Theoleyre S, Dunstan C, Heymann D, Rédini F. Wittrant Y, et al. Among authors: dunstan c. Biochem Biophys Res Commun. 2002 Apr 26;293(1):38-44. doi: 10.1016/S0006-291X(02)00179-1. Biochem Biophys Res Commun. 2002. PMID: 12054560
Characterization of osteoclast precursors in human blood.
Shalhoub V, Elliott G, Chiu L, Manoukian R, Kelley M, Hawkins N, Davy E, Shimamoto G, Beck J, Kaufman SA, Van G, Scully S, Qi M, Grisanti M, Dunstan C, Boyle WJ, Lacey DL. Shalhoub V, et al. Among authors: dunstan c. Br J Haematol. 2000 Nov;111(2):501-12. doi: 10.1046/j.1365-2141.2000.02379.x. Br J Haematol. 2000. PMID: 11122091
The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
Padagas J, Colloton M, Shalhoub V, Kostenuik P, Morony S, Munyakazi L, Guo M, Gianneschi D, Shatzen E, Geng Z, Tan HL, Dunstan C, Lacey D, Martin D. Padagas J, et al. Among authors: dunstan c. Calcif Tissue Int. 2006 Jan;78(1):35-44. doi: 10.1007/s00223-005-0161-1. Epub 2005 Dec 5. Calcif Tissue Int. 2006. PMID: 16362459
Correlates of osteoprotegerin levels in women and men.
Khosla S, Arrighi HM, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL. Khosla S, et al. Among authors: dunstan c. Osteoporos Int. 2002 May;13(5):394-9. doi: 10.1007/s001980200045. Osteoporos Int. 2002. PMID: 12086350
152 results
Jump to page